ConductScience.org, home

Paper7075643

Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Hallengren B and 5 others. Eur J Clin Pharmacol, 1982. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol. Papers, record 7075643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7075643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2019-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hallengren BB
2Nilsson ORO R
3Karlberg BEB E
4Melander AA
5Tegler LL
6Wåhlin-Boll EE

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtenololMajor topic
HyperthyroidismMajor topic
MethimazoleMajor topic
MetoprololMajor topic
PropanolaminesMajor topic
PropranololMajor topic
Administration, Oral
Female
Humans
Kinetics
Male
Metabolic Clearance Rate
Middle Aged

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14113263Measurement of thyroxine by competitive protein binding.Clin Chim Acta1972https://conductscience.org/library/papers/4113263PubMed
24998976Radioimmunoassay for triiodothyronine (T 3 ): I. Affinity and specificity of the antibody for T 3 .J Clin Endocrinol Metab1971https://conductscience.org/library/papers/4998976PubMed
3797503Drug metabolism in thyroid disease.Clin Pharmacokinet1976https://conductscience.org/library/papers/797503PubMed
414329218DRUG TOXICITY AS A RESULT OF INTERFERENCE WITH PHYSIOLOGICAL CONTROL MECHANISMS.Ann N Y Acad Sci1965https://conductscience.org/library/papers/14329218PubMed
55769417Effect of hyperthyroidism and hypothyroidism on the metabolism of testosterone and androstenedione in man.J Clin Endocrinol Metab1969https://conductscience.org/library/papers/5769417PubMed
67439251Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7439251PubMed
77438675Effects of thyroid dysfunction on propranolol kinetics.Clin Pharmacol Ther1980https://conductscience.org/library/papers/7438675PubMed
87356900The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7356900PubMed
96156842Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6156842PubMed
101122669Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1122669PubMed
111079686Quantitative determination of metoprolol in plasma and urine by gas chromatography.Acta Pharmacol Toxicol (Copenh)1975https://conductscience.org/library/papers/1079686PubMed
12484256Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.Acta Med Scand1979https://conductscience.org/library/papers/484256PubMed
13546856Atenolol determination by high-performance liquid chromatography and fluorescence detection.J Chromatogr1979https://conductscience.org/library/papers/546856PubMed
14762208Determination of propranolol and six metabolites in human urine by high-pressure liquid chromatography.J Chromatogr1979https://conductscience.org/library/papers/762208PubMed
15913002Clinical pharmacokinetics of hydrallazine.Clin Pharmacokinet1977https://conductscience.org/library/papers/913002PubMed
1675549Antithyroid drugs.Pharmacol Ther B1978https://conductscience.org/library/papers/75549PubMed
177400298Effects of antithyroid drugs on lymphocyte function in vitro.J Clin Endocrinol Metab1980https://conductscience.org/library/papers/7400298PubMed
1813958Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet1976https://conductscience.org/library/papers/13958PubMed
19508524Altered pharmacokinetics of propranolol in hyperthyroidism [proceedings].Br J Clin Pharmacol1979https://conductscience.org/library/papers/508524PubMed
2022454959Plasma concentrations of methimazole, a metabolite of carbimazole, in hyperthyroid patients.Br J Clin Pharmacol1974https://conductscience.org/library/papers/22454959PubMed

See all 24 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
38347465Influence of metabolic state and body composition on the action of pharmacological treatment of migraine.J Headache Pain2024https://conductscience.org/library/papers/38347465PubMed
6144501Use of beta-adrenoceptor blocking drugs in hyperthyroidism.Drugs1984https://conductscience.org/library/papers/6144501PubMed
6132696Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.Clin Pharmacokinet1983https://conductscience.org/library/papers/6132696PubMed
4042519Pharmacokinetic properties and bioavailability of methimazole.Clin Pharmacokinet1985https://conductscience.org/library/papers/4042519PubMed
3325214Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.Clin Pharmacokinet1987https://conductscience.org/library/papers/3325214PubMed
3305681Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages.J Endocrinol Invest1987https://conductscience.org/library/papers/3305681PubMed
3304770Pharmacokinetics of long acting propranolol. Implications for therapeutic use.Clin Pharmacokinet1987https://conductscience.org/library/papers/3304770PubMed
2940080Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.Drugs1986https://conductscience.org/library/papers/2940080PubMed
2886244Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.Clin Pharmacokinet1987https://conductscience.org/library/papers/2886244PubMed
1720383Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.Drugs1991https://conductscience.org/library/papers/1720383PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7075643

GET https://conductscience.org/api/papers/v1/7075643/references?page=2